Late relapse of non-seminoma of the testis

被引:0
|
作者
Paluchowska, B
Madej, G
Wiechno, P
Skoneczna, I
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrences of non-seminoma of the testis occurring after disease-free period longer than 2 years are very uncommon. We have analysed all patients (pts) with nonseminomatous germ cell tumor of the testis (NCGCT) who were treated in the Cancer Center in Warsaw between 1978 and 1995 and relapsed more than 24 months after complete remission. in the whole group of 711 pts, seven (1%) had late recurrence. Most of them had initial stage II disease and histological examination of the primary tumor in most cases revealed presence of teratoma or carcinoma embryonale. At late relapse 3/7 pts had increased AFF level, one Ft had increased AFP and HCG, After second line treatment only 1 patient has been disease-free for 12 months. Three pls died of disseminated NSGCT, one is alive with progressive disease and 2 pts are treated now.
引用
收藏
页码:593 / 596
页数:4
相关论文
共 50 条
  • [1] CHEMOTHERAPY OF NON-SEMINOMA TUMORS OF THE TESTIS
    ABELE, R
    ROZENCWEIG, M
    NOUVELLE PRESSE MEDICALE, 1980, 9 (45): : 3449 - 3454
  • [2] LYMPHOGRAPHY IN THE DIAGNOSIS OF NON-SEMINOMA TUMORS OF THE TESTIS
    WOBBES, T
    BLOM, JMH
    OLDHOFF, J
    KOOPS, HS
    JOURNAL OF SURGICAL ONCOLOGY, 1982, 19 (01) : 1 - 4
  • [3] Conditional survival of stage III non-seminoma testis cancer patients
    Incesu, Reha-Baris
    Barletta, Francesco
    Tappero, Stefano
    Morra, Simone
    Garcia, Cristina Cano
    Scheipner, Lukas
    Piccinelli, Mattia Luca
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    de Cobelli, Ottavio
    Ahyai, Sascha
    Chun, Felix K. H.
    Longo, Nicola
    Terrone, Carlo
    Briganti, Alberto
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 435.e11 - 435.e18
  • [4] Risk factors for testicular cancer - differences between pure non-seminoma and mixed seminoma/non-seminoma?
    Aschim, E. L.
    Haugen, T. B.
    Tretli, S.
    Daltveit, A. K.
    Grotmol, T.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2006, 29 (04): : 458 - 467
  • [5] Survival differences in non-seminoma testis cancer patients according to race/ethnicity
    Incesu, Reha-Baris
    Barletta, Francesco
    Tappero, Stefano
    Piccinelli, Mattia Luca
    Garcia, Cristina Cano
    Morra, Simone
    Scheipner, Lukas
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    Ahyai, Sascha
    Longo, Nicola
    Chun, Felix K. H.
    de Cobelli, Ottavio
    Terrone, Carlo
    Briganti, Alberto
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    CANCER EPIDEMIOLOGY, 2024, 89
  • [6] Genetic bases of testicular seminoma and non-seminoma tumors
    Martin-Gimeno, Paloma
    Paumard-Hernandez, Beatriz
    Calvete, Oriol
    Benitez, Javier
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer
    Klepp, O
    Dahl, O
    Flodgren, P
    Stierner, U
    Olsson, AM
    Oldbring, J
    Nilsson, S
    Daehlin, L
    Tornblom, M
    Smaland, R
    Starkhammar, H
    Abramsson, L
    Wist, E
    Raabe, N
    Edekling, T
    CavallinStahl, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) : 1038 - 1044
  • [8] NON-SEMINOMA TESTIS TREATED BY IRRADIATION AT THE ROTTERDAMSCH-RADIOTHERAPEUTISCH-INSTITUUT - THE RISK OF METASTASIS
    VANDERWERFMESSING, BHP
    AUERBACH, WM
    VANPUTTEN, WLJ
    RADIOTHERAPY AND ONCOLOGY, 1984, 2 (02) : 101 - 105
  • [9] Treatment of clinical stage Ⅰ non-seminoma
    Christian Winter
    Ahareas Hiester
    Asian Journal of Urology, 2021, (02) : 161 - 169
  • [10] Weakness and numbness after chemotherapy for metastatic non-seminoma testis: A new neurological complication
    Verdonk, Robert C.
    Enting, Roelien H.
    Janmaat, Mirjam
    Schroder, Caroline P.
    Sleijfer, Dirk Th.
    Gietema, Jourik A.
    ACTA ONCOLOGICA, 2008, 47 (08) : 1596 - 1598